LAURA ORTEGA: Open Payments
NPI 1245765494 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,435 in 64 payments from 15 companies in 2025. Trend: 2023 $860 · 2024 $1,038 · 2025 $1,435
Food & beverage: $1,419Education: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $438 |
| Novo Nordisk Inc | 11 | $262 |
| ABBVIE INC. | 12 | $204 |
| Lilly USA, LLC | 7 | $132 |
| Nalu Medical, Inc. | 1 | $112 |
| Amgen Inc. | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Exact Sciences Corporation | 2 | $41 |
| Radius Health, Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $28 |
Products named: Ozempic, FARXIGA, BREZTRI, Nalu Neurostimulation System, AIRSUPRA, LINZESS, MOUNJARO, JARDIANCE.
Industry payments across NM — which companies pay providers there.
